Transdermal therapeutic system containing hormones and crystallization inhibitors
US6899894B1 · kind B1 · utility
15Cited by
13References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 8, 1999 |
| Grant date | May 31, 2005 |
| Priority date | — |
| Expiry date | Jun 8, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/939
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A transdermal therapeutic system in plaster form for controlled release of oestradiol in combination with norethisterone acetate, comprising a backing layer, a reservoir supersaturated with active ingredients which is attached to said backing layer and prepared using polyacrylate pressure-sensitive adhesives and crystallization inhibitors, and a detachable protective layer, is characterized in that the crystallization inhibitor is an amino-containing polymer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.